Medicines in Development for Health Equity 2021 Report

A teaser image of the first page of PhRMA's 2021 Medicines in Development for Health Equity report

Today, there are more than 800 medicines in development for diseases that disproportionately affect racial and ethnic communities. A new report from PhRMA explores these medicines that target these diseases and conditions, which not only affect these racial and ethnic communities at a higher rate, but are also associated with worse COVID-19 outcomes.

Interested in reading more about Medicines in Development for Health Equity in 2021?

Get your free copy of the report now.